The treatment potential in preventive cardiology

Atherosclerosis Supplements

Volumn 2, Issue 1, 2001, Pages 3-8

  Wood, David ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

CHD; EUROASPIRE; Preventive cardiology

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

AGE DISTRIBUTION; ANTIHYPERTENSIVE THERAPY; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CLINICAL PRACTICE; CLINICAL TRIAL; CONFERENCE PAPER; CORONARY ARTERY BYPASS SURGERY; CORONARY RISK; DIAGNOSTIC VALUE; ELECTIVE SURGERY; EMERGENCY SURGERY; EPIDEMIOLOGICAL DATA; FOOD INTAKE; HEALTH BEHAVIOR; HIGH RISK PATIENT; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; LIFESTYLE; MEDICAL SOCIETY; MORBIDITY; MORTALITY; OBESITY; PHYSICAL ACTIVITY; PREVALENCE; PREVENTIVE MEDICINE; PRIORITY JOURNAL; RISK MANAGEMENT; RISK REDUCTION; SEX DIFFERENCE; SMOKING CESSATION; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT PLANNING; BLOOD; BLOOD PRESSURE; CORONARY ARTERY DISEASE; FEMALE; MALE; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; RISK FACTOR;

BLOOD PRESSURE; CHOLESTEROL; CHOLESTEROL, LDL; CORONARY DISEASE; FEMALE; HUMANS; MALE; RISK FACTORS;

EID: 0035257564     PISSN: 15675688     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5688(00)00003-9     Document Type: Conference Paper

References (18)

1. Sans S., Kesteloot H., Kromhout D. The burden of cardiovascular diseases mortality in Europe. Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe. Eur. Heart J. 18:1997;231-248.
2. Pyörälä K., De Backer G., Graham I., Poole-Wilson P.A., Wood D.A. Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. Eur. Heart J. 15:1994;1300-1331.
3. Wood D.A., De Backer G., Faergeman D., Graham I., Mancia G., Pyörälä K. Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention. Eur. Heart J. 19:1998;1434-1503.
4. A British Cardiac Society survey of the potential for the secondary prevention of coronary disease: ASPIRE (Action on Secondary Prevention through Intervention to Reduce Events). Heart. 75:1996;334-342.
5. EUROASPIRE. A European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results. Eur. Heart J. 18:1997;1569-1582.
6. Pearson T.A., Peters T.D. The treatment gap in coronary artery disease and heart failure: community standards and the post-discharge patient. Am. J. Cardiol. 80:(8B):1997;45H-52H.
7. Pearson T.A., Peters T.D., Feury D. Comprehensive risk reduction in coronary patients: attainment of goals of the AHA Guidelines in U.S. patients. Circulation. 96:1997;1-733. Abstract.
8. Pearson T.A., Peters T.D., Fury D. Screening of first degree relatives after the onset of coronary disease: a missed opportunity. Circulation. 96:1997;1-374. Abstract.
9. Keech A., Zambahary R., Ritchie G., Thongtang V., White H., Carruthers A., Kalim H. Hypercholesterolaemia as a risk factor for coronary heart disease in the Asia-Pacific region. The ASPAC study. Atherosclerosis. 151:2000;83. Abstract.
10. Yamamoto A., Dans A., Ritchie G., MacMahon S., Nontakanun S., Keech A. Prevalence of hypertension in CHD patients in the Asia-Pacific region: the ASPAC study. Atherosclerosis. 151:2000;255. Abstract.
11. Ritchie G., Lai M., Park Y., Tamesis B., Tan A., Carruthers A., Keech A. Prevalence of smoking among CHD patients in the Asia-Pacific: the ASPAC study. Atherosclerosis. 151:2000;279. Abstract.
12. de Oya M., Lopez-Sendon J.L., de Teresa E., Velasco-Rami J., Villa E., Cosin J. The impact of landmark clinical trials on secondary prevention of acute myocardial infarction (AMI) in Spain. PREVESE 98 study. Atherosclerosis. 151:2000;107. Abstract.
13. Danchin N., Grenier O., Ferrieres J., Cambou J.P. Secondary prevention of patients with acute coronary syndrome in France: results of the PREVENIR survey. Eur. Heart J. 20:1999;664. Abstract.
14. Cambou J.P., Grenier O., Ferrieres J., Danchin N. Secondary prevention in elderly patients with acute coronary syndrome in France: results of the PREVENIR survey. Eur. Heart J. 20:1999;663. Abstract.
15. Grenier O., Cambou J.P., Ferrieres J., Danchin N. Secondary prevention in women with acute coronary syndrome in France: results of the PREVENIR survey. Eur. Heart J. 20:1999;656. Abstract.
16. De Velasco J.A., Cosin J., Lopez-Sendon J.L., et al. Secondary prevention of myocardial infarction in Spain. The PREVESE study (La prevencion secundaria del infarto de miocardio en Espana Estudio PREVESE). Rev. Esp. Cardiol. 50:1997;406-415.
17. McBride P., Schrott H.G., Plane M.B., Underbakke G., Brown R.L. Primary care practice adherence to National Cholesterol Education Programme guidelines for patients with coronary heart disease. Arch. Intern. Med. 158:1998;1238-1244.
18. Majumdar S.R., Gurwitz J.H., Soumerai S.B. Undertreatment of hyperlipidaemia in the secondary prevention of coronary artery disease. J. Gen. Intern. Med. 12:1999;711-717.